Logo
S

Slingshot Biosciences

64 employees

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cell Engineering
Cell Therapies
FACS
Synthetic Biology
Biotech
Hematology
Flow Cytometry
Image Cytometry
Therapeutics
Life Sciences
Cell Analysis
CAR-T
Medical

Date founded

2012

Funding rounds raised

Total raised

$23M

from 6 investors over 6 rounds

S

Slingshot Biosciences raised $11M on February 6, 2023

Investors: Anterra Capital, ARCH Venture Partners and Northpond Ventures

S

Slingshot Biosciences raised $23M on July 22, 2021

Investors: Anterra Capital, Northpond Ventures and ARCH Venture Partners

FAQ